New short blogpost! I wrote a round up of cancer research news from ASCO2026: - Daraxonrasib, the breakthrough pancreatic cancer drug - Big 7-year results of lorlatinib for ALK+ lung cancers – Talazoparib, a prostate cancer drug that cut the risk of progression by half and much more. Read here:
abundanceandgrowth.orgCancer breakthroughs at ASCOA What we're reading spotlight
22 reposts55 likes